Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.51 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30725689 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL18334383 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL4321053 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL21433647 | 0.92 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL18334355 | 0.89 | ALDH1A1 (0.61) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL6327767 | 0.89 | ALDH1A1 (0.52) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL31619944 | 0.89 | ALDH1A1 (0.61) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL18334356 | 0.89 | ALDH1A1 (0.61) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL6587051 | 0.88 | ALDH1A1 (0.59) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL29517181 | 0.87 | ALDH1A1 (0.50) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115960088-B | Novel coronavirus main protease inhibitor and preparation method and application thereof | 四川大学 | 2024-07-26 | — | — | CN | disclosed |
| CN-115960088-A | Novel coronavirus main protease inhibitor, preparation method and application thereof | 四川大学 | 2023-04-14 | — | — | CN | disclosed |
| CN-114057702-B | Novel inhibitor of coronavirus main protease and preparation method and application thereof | 四川大学 | 2022-09-30 | — | — | CN | disclosed |
| WO-2022021841-A1 | NOVEL CORONAVIRUS MAIN PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 四川大学 | 2022-02-03 | — | — | WO | disclosed |
| US-20070129366-A1 | Methods for the treatment of chronic pain and compositions therefor | BUXTON FRANCIS P | 2007-06-07 | — | — | US | disclosed |
| US-20070129366-A1 | Methods for the treatment of chronic pain and compositions therefor | BUXTON FRANCIS P | 2007-06-07 | — | — | US | disclosed |
| EP-0442754-B1 | Reagents and methods for stereospecific fluoromethylation | PROTOTEK INC (US) | 1995-12-27 | — | — | EP | disclosed |
| US-5344939-A | Esterification | PROTOTEK, INC. (US) | 1994-09-06 | — | — | US | disclosed |
| US-5210272-A | Using a magnesium fluoromalonate to fluoromethylate a carboxylic acid | PROTOTEK, INC. (US) | 1993-05-11 | — | — | US | disclosed |
| US-5101068-A | Monofluoromethylation of organic compounds, reaction with amino acids | PROTOTEK INC. (US) | 1992-03-31 | — | — | US | disclosed |
| EP-0442754-A2 | Reagents and methods for stereospecific fluoromethylation | PROTOTEK, INC., (US) | 1991-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129366-A1 | Methods for the treatment of chronic pain and compositions therefor | CTSS, CTSF, CTSG | ALDH1A1 1324/4885TDP1 4143/4885MAPK1 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.